Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial (Q45297326)
Jump to navigation
Jump to search
scientific article published on 2 September 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial |
scientific article published on 2 September 2016 |
Statements
1 reference
Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial (English)
1 reference
Eugene R Bleecker
1 reference
J Mark FitzGerald
1 reference
Pascal Chanez
1 reference
Alberto Papi
1 reference
Steven F Weinstein
1 reference
Peter Barker
1 reference
Stephanie Sproule
1 reference
Geoffrey Gilmartin
1 reference
Magnus Aurivillius
1 reference
Viktoria Werkström
1 reference
Mitchell Goldman
1 reference
SIROCCO study investigators
1 reference
2 September 2016
1 reference
1 reference
388
1 reference
10056
1 reference
2115-2127
1 reference
Identifiers
1 reference
1 reference